Latest News and Press Releases
Want to stay updated on the latest news?
-
Successfully completed initial public offering, raising $71.4 million in gross proceedsPresented data on AXA1665 and AXA1125 at two leading medical conferencesIdentified drug development path for...
-
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated...
-
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated...